いさぎよくsingle life ここちよくsimple life 


DMM英会話DailyNews予習復習メモ:Psychedelic Drug Used to Treat Depression in Canada  

昨日の記事に引き続き マジックマッシュルームの使用許可。カナダの場合、 今までは末期患者に許されていたのが、今回の記事ではうつ病など精神疾患も持っている小康状態のがん患者が許可された。

今回の講師Frankyからお褒め過ぎのお言葉をlesson noteに頂きました↓ので一部載せさせてください(^_-)-☆

You're very conversant and eager to learn. I could notice how you practiced harder and prepared for today. I appreciated so much of your hard work. It showed your good effort and understanding.  


total time 51025minutes 2020/11/25 level 9


 Photo by Thought Catalog on Unsplash

 Psychedelic Drug Used to Treat Depression in Canada

  幻覚ドラッグうつ病治療に使用 カナダで


The Canadian government has let a 67-year-old woman undergo psychedelicsὰɪkədélɪk therapy to help with her anxiety and depression.

Mona Strelaeff of Victoria, British Columbia, is believed to be the first person {who isn't terminally ill to be allowed }to take psilocybinsaɪləˈsaɪbɪn legally in the country.








Psilocybin, which is the active ingredient in psychedelic mushrooms — also called "magic mushrooms" — is illegal to produce, possess and sell in Canada except for approved research purposes and under certain exemptions.





According to TeraPsil, a group working to promote the use of psilocybin for treatment, in August Canada's Minister of Health allowed four people with terminal illnesses to take the drug to help with their end-of-life care.

They were the first patients known to be allowed to do so since psilocybin was made illegal in Canada in 1974.







Strelaeff suffered from depression while in remission from breast cancer, which she was diagnosed with 12 years ago.

She told Vice she was allowed to take the drug to help her deal with trauma from her cancer as well as issues from her childhood. She said the treatment helped her get over her tough memories.


彼女は乳がん小康状態の時、うつ病で苦しんでいた。 乳がんは12年前に診断された






Several studies around the world have shown that psilocybin treatments could be able to help with illnesses like depression, anxiety and post-traumatic stress disorder.




Imperial College London's Centre for Psychedelic Research is looking into the use of psychedelics for treating depression, saying that early research shows promise for treating serious mental health conditions.






Researchers at the Johns Hopkins University School of Medicine in Baltimore, Maryland, found that 32% of patients who had life-threatening cancer as well as depression or anxiety showed a significant improvement in mood five weeks after taking a low dose of psilocybin. The improvement was seen in 92% of those given a high dose of the drug.









 TheraPsil, which helped with Strelaeff's treatment, said the exemptions in Canada have opened the door to further therapies using the drug, and the group plans to launch a training program for those who want to practice psychedelic therapy by January.